Search

Search Results
Results 7491 - 7500 of 17271 for Active treatment
  • News - 20 Feb 2026
    Tropical cyclones, including hurricanes and tropical storms, are linked to increased rates of drug-related deaths up to three months after the storm passes-particularly in higher-income, White...
  • Drug - 18 Feb 2026
    Consumer Medicine Information (CMI) about Tresiba Penfill intended for persons living in Australia.
  • Drug - 13 Feb 2026
    Consumer Medicine Information (CMI) about Omjjara intended for persons living in Australia.
  • Drug - 13 Feb 2026
    Consumer Medicine Information (CMI) about Blenrep intended for persons living in Australia.
  • Drug - 12 Feb 2026
    Consumer Medicine Information (CMI) about NovoRapid Vial intended for persons living in Australia.
  • News - 11 Feb 2026
    Researchers engineered CD4+ chimeric antigen receptor T cells targeting fibrillar amyloid beta and tested them in a mouse Alzheimer model. The preclinical study showed reduced amyloid pathology and...
  • Drug - 11 Feb 2026
    Consumer Medicine Information (CMI) about DBL Promethazine Hydrochloride intended for persons living in Australia.
  • News - 10 Feb 2026
    Eric Gaier, MD, PhD, and Dean Eliott, MD, of the Department of Ophthalmology at Mass Eye and Ear, a member of the Mass General Brigham healthcare system, are co-authors of a paper published in...
  • Drug - 9 Feb 2026
    Consumer Medicine Information (CMI) about Retrieve intended for persons living in Australia.
  • News - 6 Feb 2026
    Hormone replacement therapy applied via the skin is the best way of protecting bone density in women whose periods have stopped due to anorexia or intense exercise, according to new research from...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.